NS Pharma, Inc.
Rob Jacobs has a strong background in pharmaceutical marketing and sales. Rob has held various leadership positions at companies such as NS Pharma, Tris Pharma, Mallinckrodt Pharmaceuticals, Daiichi Sankyo, Novartis, and Pharmacia. Rob has experience in brand management, product management, and sales representation. Rob holds an MBA from Syracuse University.
NS Pharma, Inc.
2 followers
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”.